Research progress of Pseudomonas aeruginosa transcription factor PsrA

doi:10.3969/j.issn.1673-8640.2020.08.021

Abstract

CLC Number:

R446.1

LI Chanchan, WANG Ru, LUO Wenying. Research progress of Pseudomonas aeruginosa transcription factor PsrA[J]. Laboratory Medicine, 2020, 35(8): 832-836.

References 33

[1]	2015年全国细菌耐药监测报告[J]. 中国执业药师,2016,13(3):3-8.
[2]	GEORGI C,BUERGER J,HILLEN W,et al. Promoter strength driving TetR determines the regulatory properties of Tet-controlled expression systems[J]. PLoS One,2012,7(7):e41620.
[3]	RAMOS J L,MARTÍNEZ-BUENO M,MOLINA-HENARES A J,et al. The TetR family of transcriptional repressors[J]. Microbiol Mol Biol Rev,2005,69(2):326-356.
[4]	FONSECA P,DE LA PEÑA F,PRIETO M A,et al. A role for the regulator PsrA in the polyhydroxyalkanoate metabolism of Pseudomonas putida KT2440[J]. Int J Biol Macromol,2014,71:14-20.
[5]	MILLER R M,TOMARAS A P,BARKER A P,et al. Pseudomonas aeruginosa twitching motility-mediated chemotaxis towards phospholipids and fatty acids:specificity and metabolic requirements[J]. J Bacteriol,2008,190(11):4038-4049.
[6]	KAZAKOV A E,RODIONOV D A,ALM E,et al. Comparative genomics of regulation of fatty acid and branched-chain amino acid utilization in proteobacteria[J]. J Bacteriol,2009,191(1):52-64.
[7]	ZARZYCKI-SIEK J,NORRIS M H,KANG Y,et al. Elucidating the Pseudomonas aeruginosa fatty acid degradation pathway:identification of additional fatty acyl-CoA synthetase homologues[J]. PLoS One,2013,8(5):e64554.
[8]	SUN Z,KANG Y,NORRIS M H,et al.Blocking phosphatidylcholine utilization in Pseudomonas aeruginosa,via mutagenesis of fatty acid,glycerol and choline degradation pathways,confirms the importance of this nutrient source in vivo[J]. PLoS One,2014,9(7):e103778.
[9]	WILLSEY G G,VENTRONE S,SCHUTZ K C,et al. Pulmonary surfactant promotes virulence gene expression and biofilm formation in Klebsiella pneumoniae[J]. Infect Immun,2018,86(7):e00135-18.
[10]	KANG Y,NGUYEN D T,SON M S,et al. The Pseudomonas aeruginosa PsrA responds to long-chain fatty acid signals to regulate the fadBA5 beta-oxidation operon[J]. Microbiology,2008,154(Pt 6):1584-1598.
[11]	YEO H K,PARK Y W,LEE J Y. Structural basis of operator sites recognition and effector binding in the TetR family transcription regulator FadR[J]. Nucleic Acids Res,2017,45(7):4244-4254.
[12]	BYNDLOSS M X,RIVERA-CHÁVEZ F,TSOLIS R M,et al. How bacterial pathogens use type Ⅲ and type Ⅳ secretion systems to facilitate their transmission[J]. Curr Opin Microbiol,2017,35:1-7.
[13]	SHEN D K,FILOPON D,KUHN L,et al. PsrA is a positive transcriptional regulator of the type Ⅲ secretion system in Pseudomonas aeruginosa[J]. Infect Immun,2006,74(2):1121-1129.
[14]	KANG Y,LUNIN V V,SKARINA T,et al. The long-chain fatty acid sensor,PsrA,modulates the expression of rpoS and the type Ⅲ secretion exsCEBA operon in Pseudomonas aeruginosa[J]. Mol Microbiol,2009,73(1):120-136.
[15]	陈思遐,沈自燕,冯旰珠. 铜绿假单胞菌毒力因子的研究进展[J]. 国际呼吸杂志,2018,38(18):1410-1413.
[16]	YIN L M,EDWARDS M A,LI J,et al. Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions[J]. J Biol Chem,2012,287(10):7738-7745.
[17]	LATENDORF T,GERSTEL U,WU Z,et al. Cationic intrinsically disordered antimicrobial peptides(CIDAMPs) represent a new paradigm of innate defense with a potential for novel anti-infectives[J]. Sci Rep,2019,9(1):3331.
[18]	GOODERHAM W J,BAINS M,MCPHEE J B,et al. Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance,biofilm formation,and swarming motility of PsrA in Pseudomonas aeruginosa[J]. J Bacteriol,2008,190(16):5624-5634.
[19]	HAN M L,ZHU Y,CREEK D J,et al. Alterations of metabolic and lipid profiles in polymyxin-resistant Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother,2018,62(6):e02656-17.
[20]	TRIMBLE M J,MLYNÁRIK P,KOLÁ M,et al. Polymyxin:alternative mechanisms of action and resistance[J]. Cold Spring Harb Perspect Med,2016,6(10):a025288.
[21]	MO C Y,BIRDWELL L D,KOHLI R M. Specificity determinants for autoproteolysis of LexA,a key regulator of bacterial SOS mutagenesis[J]. Biochemistry,2014,53(19):3158-3168.
[22]	LAI B M,YAN H C,WANG M Z,et al. A common evolutionary pathway for maintaining quorum sensing in Pseudomonas aeruginosa[J]. J Microbiol,2018,56(2):83-89.
[23]	NOVOVIC K D,MALESEVIC M J,FILIPIC B V,et al. PsrA regulator connects cell physiology and class 1 integron integrase gene expression through the regulation of lexA gene expression in Pseudomonas spp.[J]. Curr Microbiol,2019,76(3):320-328.
[24]	MA L,CONOVER M,LU H,et al. Assembly and development of the Pseudomonas aeruginosa biofilm matrix[J]. PLoS Pathog,2009,5(3):e1000354.
[25]	LIN J,CHENG J,WANG Y,et al. The Pseudomonas quinolone signal(PQS):not just for quorum sensing anymore[J]. Front Cell Infect Microbiol,2018,8:230.
[26]	WADE D S,CALFEE M W,ROCHA E R,et al. Regulation of Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa[J]. J Bacteriol,2005,187(13):4372-4380.
[27]	NGUYEN D,JOSHI-DATAR A,LEPINE F,et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria[J]. Science,2011,334(6058):982-986.
[28]	KOHANSKI M A,DWYER D J,WIERZBOWSKI J,et al. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death[J]. Cell,2008,135(4):679-690.
[29]	DREES S L,LI C,PRASETYA F,et al. PqsBC,a condensing enzyme in the biosynthesis of the Pseudomonas aeruginosa quinolone signal:crystal structure,inhibition,and reaction mechanism[J]. J Biol Chem,2016,291(13):6610-6624.
[30]	DULCEY C E,DEKIMPE V,FAUVELLED A,et al. The end of an old hypothesis:the Pseudomonas signaling molecules 4-hydroxy-2-alkylquinolines derive from fatty acids,not 3-ketofatty acids[J]. Chem Biol,2013,20(12):1481-1491.
[31]	WELLS G,PALETHORPE S,PESCI E C. PsrA controls the synthesis of the Pseudomonas aeruginosa quinolone signal via repression of the FadE homolog,PA0506[J]. PLoS One,2017,12(12):e0189331.
[32]	COOKE A C,NELLO A V,ERNST R K,et al. Analysis of Pseudomonas aeruginosa biofilm membrane vesicles supports multiple mechanisms of biogenesis[J]. PLoS One,2019,14(12):e0212275.
[33]	CIOFU O,TOLKER-NIELSEN T. Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents-How P. aeruginosa can escape antibiotics[J]. Front Microbiol,2019,10:913.

Research progress of Pseudomonas aeruginosa transcription factor PsrA

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 33

Related Articles 15

Recommended Articles

Metrics

[1]	FEI Bing, LIU Ying, REN Yanying, GUO Mengyu, LIU Xinwei, LIU Dongmei, LI Yongwei. Research progress of cyclic diguanylate on the regulation of Pseudomonas aeruginosa biofilm [J]. Laboratory Medicine, 2023, 38(2): 186-189.
[2]	CHEN Qing, XU Rong, SUN Jingyong. Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa from patients with bronchiectasis in Shanghai [J]. Laboratory Medicine, 2023, 38(11): 1020-1025.
[3]	SUN Wei, XIA Shuai, FAN Yujian, MA Liyan. Drug resistance and biofilm formation abilities of Corynebacterium striatum with different genotypes [J]. Laboratory Medicine, 2022, 37(6): 505-509.
[4]	ZHANG Guanyi, YAO Dongting, WANG Jian, HU Xiaobo. Research progress on Chinese and western medicine treatment for Candida glabrata infection [J]. Laboratory Medicine, 2021, 36(7): 761-765.
[5]	ZHOU Yanxia, JIN Dongfang. Inhibition and mechanism of tannic acid on biofilm formation in Klebsiella pneumoniae [J]. Laboratory Medicine, 2021, 36(10): 1070-1073.
[6]	ZHONG Feng, FENG Yi, ZHANG Jingjing, XU Yan, FANG Yongmei, TAO Xiubin, WU Jing. In vitro antimicrobial activity and biofilm inhibitory effect of imipenem combined with tigecycline against mucoid Pseudomonas aeruginosa [J]. Laboratory Medicine, 2020, 35(6): 519-523.
[7]	SUN Kangde, ZHANG Jiasheng, CHEN Xu, YU Zhongmin, CHEN Fuxiang. Correlations of virulence factor expression and drug resistance for Candida albicans isolated from oral cavity [J]. Laboratory Medicine, 2019, 34(8): 730-735.
[8]	MO Qianqian, MO Jiaguang. Research progress on the relationship between drug resistance and controlling biofilm formation by sRNA [J]. Laboratory Medicine, 2017, 32(6): 549-552.
[9]	SUN Kangde, CHEN Cheng, CHEN Xu, ZHANG Jiasheng, YU Zhongmin, CHEN Fuxiang. Drug resistance and genotypes of oral Candida albicans and expressions of drug-resistant genes of oral Candida albicans [J]. Laboratory Medicine, 2017, 32(11): 979-984.
[10]	FAN Xuemei. Efficiency of azithromycin and tobramycin drug combination on Pseudomonas aeruginosa [J]. Laboratory Medicine, 2017, 32(10): 879-882.
[11]	HUANG Qiulan, FAN Deping, GAO Shouxia, LIU Hongchou, XUE Nali, NI Yuxing. Class Ⅰ integron for diagnosing imipenem resistance of Pseudomonas aeruginosa：a Meta-analysis [J]. Laboratory Medicine, 2016, 31(6): 491-498.
[12]	XU Weihong, XU Bin, YAO Yiting, HUANG Mingmin, ZHANG Jun, ZHAO Hu. Analysis of AmpC beta-lactamase and outer membrane porin OprD₂ gene deletion in Pseudomonas aeruginosa [J]. Laboratory Medicine, 2016, 31(4): 309-313.
[13]	SHU Wen, QIAN Ying, LIU Qingzhong. Drug resistance of Pseudomonas aeruginosa in a teaching hospital from 2010 to 2014 [J]. Laboratory Medicine, 2016, 31(12): 1055-1060.
[14]	PENG Jinghong, HOU Yanqiang, XIE Duoshuang, LIU Jun, ZHENG Rong. Studies of 16S rRNA methylase gene and aminoglycoside modifying enzyme gene in Pseudomonas aeruginosa [J]. Laboratory Medicine, 2015, 30(6): 613-616.
[15]	XIE Fandi, NIU Shumeng, SHI Jinjie, ZHANG Wenyan. Relationship between STEC biofilm formation ability and the expression of virulence genes [J]. Laboratory Medicine, 2015, 30(6): 617-621.